Skip to main content

Promus PREMIER™

Everolimus-Eluting Platinum Chromium Coronary Stent System

PLATINUM Long Lesion Trial

Platinum Chromium Everolimus-Eluting Clinical Experience

Study Objective: Evaluate the safety and effectiveness of the Promus PtCr EES Stent System1 for the treatment of patients with a de novo lesion > 24 and ≤ 34 mm in length; ≥ 2.50 mm to ≤ 4.25 mm in diameter

Study Design: Prospective, Single-arm, Multicenter

 

Indications, Safety, and Warnings
Request a Sales Rep
icon-contact-email-update

Sign-up for Product Updates

 icon-contact-email

Submit Your Questions

Long Lesion Data in Perspective

0% ARC ST (Def/Prob) and 0% TV-MI

PLATINUM Long Lesion Trial

2-Year Results2

Promus EES stent incident rate on long lesions

4.8% TV-MI

SPIRIT PRIME Long Lesion Registry

2-Year Results in Perspective3,4

Xience Everolimus Drug-Eluting Stent 4.8% TV-MI
Top